Herbalife (HLF) is back in focus after its second quarter 2026 update, which combined higher sales, a swing to a quarterly net loss, raised full year sales guidance, and confirmation of an upcoming CFO transition.

The earnings release and CFO succession plan have come alongside a more mixed share price path for Herbalife. The stock has a 1 day share price return of 7.3%, although the 30 day share price return is down 6.1%. Momentum has faded compared to a 1 year total shareholder return of 38.8%, and a 5 year total shareholder return that is down 75.0%.

If Herbalife’s update has you reassessing where growth and risk are shifting, this can be a good moment to broaden your search and check out 19 top founder-led companies

Bulls point to Herbalife’s higher sales, raised full year guidance and discounted share price. Bears focus on the recent quarterly loss and long term share price pressure. Which side does the valuation picture lean toward next?

Most Popular Narrative: 27.4% Undervalued

The most followed narrative on Herbalife sees fair value at $17.00 compared with the last close of $12.35, which points to a sizeable valuation gap that hinges on how the next few years of earnings and margins play out.

The analysts have a consensus price target of $17.0 for Herbalife based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $9.0.

Want to see what underpins that gap between price and fair value? The narrative leans heavily on a specific earnings path, firming margins, and a compressed future earnings multiple.

Result: Fair Value of $17 (UNDERVALUED)

However, Herbalife still faces regulatory scrutiny of its multi level marketing model and changing consumer preferences around supplements, which could undermine this undervalued narrative.

Next Steps

With Herbalife’s combination of optimism around valuation and concern about execution risk, it is useful to understand both sides clearly and act promptly by reviewing the 3 key rewards and 5 important warning signs

Looking for more investment ideas beyond Herbalife?

If Herbalife’s story has you thinking harder about where to put your money next, do not stop here. Broaden your watchlist with a few focused stock ideas.

• Target steadier cash flows by checking companies with healthy financial footing using the solid balance sheet and fundamentals stocks screener (48 results).
• Hunt for potential value gaps by scanning companies that look attractively priced through the 52 high quality undervalued stocks.
• Spot under-the-radar opportunities early by reviewing the screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.